GnRH Deficiency: Clinical Trials

5 trials for GnRH Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4

Follow GnRH Deficiency: new trials by email Literature Review of GnRH Deficiency trials Research Report on GnRH Deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Kisspeptin in the Evaluation of Delayed Puberty
kisspeptin 112-121, GnRH - Delayed Puberty, Kallmann Syndrome
Phase 1CompletedMassachusetts General Hospital242013-06-082023-10-19
Kisspeptin Administration in the Adult
kisspeptin 112-121, GnRH - Hypogonadotropic Hypogonadism, Kallmann Syndrome
Phase 1CompletedMassachusetts General Hospital2562009-06-232024-07-31
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
Hypogonadotropic Hypogonadism, Kallmann Syndrome
CompletedMassachusetts General Hospital40421999-01-012022-06-30
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
gonadotropin releasing hormone (GnRH) - Kallmann Syndrome, Idiopathic Hypogonadotropic Hypogonadism
Phase 1CompletedMassachusetts General Hospital271999-01-012022-07-01
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
gonadotropin releasing hormone (GnRH) - Kallmann Syndrome, Hypogonadotropic Hypogonadism
Phase 1CompletedMassachusetts General Hospital6241989-04-012022-07-11

Narrower conditions

Kallmann Syndrome (5)  ·  Hypogonadism (4)  ·  Idiopathic Hypogonadotropic Hypogonadism (2)  ·  Puberty, Delayed (2)  ·  Hyperprolactinemia (1)  ·  Polycystic Ovary Syndrome (1)  ·  Puberty, Precocious (1)

Broader conditions

Congenital Abnormalities (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Disorder of Sex Development, 46,XY (5)  ·  Disorders of Sex Development (5)  ·  Endocrine System Diseases (5)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Genetic Diseases, Inborn (5)  ·  Gonadal Disorders (5)  ·  Male Urogenital Diseases (5)  ·  Urogenital Abnormalities (5)  ·  Urogenital Diseases (5)  ·  Adnexal Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)

Interventions

Gonadotropin-Releasing Hormone (4)

Sponsors

Massachusetts General Hospital (5)

Countries

United States (5)

Top investigators

Stephanie B Seminara, MD (4)  ·  Seminara B Stephanie, MD (1)

Results publications

PMID 21209029, PMID 31132118, PMID 11788640, PMID 12213860, PMID 12788881, PMID 14573733, PMID 15613419, PMID 16606836, PMID 16757106, PMID 16764984, PMID 17074994, PMID 17334928, PMID 17761590, PMID 17959774, PMID 18272894, PMID 19021638, PMID 19567835, PMID 19829004, PMID 20332248, PMID 20382682, PMID 20484732, PMID 20696889, PMID 21037178, PMID 2122732, PMID 21247312, PMID 21700882, PMID 22072740, PMID 22319038, PMID 22745237, PMID 22773735, PMID 23378218, PMID 23533228, PMID 23643382, PMID 24476074, PMID 2502554, PMID 25226293, PMID 29669934, PMID 3096182, PMID 3098771, PMID 32034419, PMID 32232399, PMID 32870266, PMID 3900124, PMID 39965102, PMID 41273106, PMID 6767977, PMID 6813732, PMID 9010147, PMID 9174769, PMID 9922906

NIH funding

U54HD028138 (2)